SYNBIOTIC SE
NuWays RecommendationRecommendation
Buy
Price Target
€12.40
Upside
325.39%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€2.92
-€0.02 (-0.51%)
Realtime-Data from 15.09.2025 13:43:22
SYNBIOTIC is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
ISIN
DE000A3E5A59
Market Cap
€16.32M
Enterprise Value
€19.40M
26 week avg vol.
5599537
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
Munich, DE
Employees
75
Incorporated
2015
CEO
Daniel Kruse
Website
Institutional Investors
47.00%
Management
7.60%
Free Float
45.40%
Sep 25
Annual General Meeting
Sep 25
Publication half yearly financial report
KPIs in EUR
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| Sales | 3.86M | 15.92M | 22.99M |
| EBITDA | -7.19M | -1.01M | 1.84M |
| EBIT | -11.75M | -2.13M | 756.62K |
| EPS | -2.12 | -0.30 | 0.06 |
| FCF | -2.94M | -4.33M | 1.35M |
Valuation
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| EV / Sales | 5.02x | 1.20x | 0.77x |
| EV / EBITDA | (2.70x) | (18.86x) | 9.68x |
| EV / EBIT | (1.65x) | (8.98x) | 23.49x |
| Price / Earnings | (1.37x) | (9.57x) | 48.26x |
| EV / FCF | (6.59x) | (4.42x) | 13.13x |
Downloads
Latest Research
Initiation